Abstract
The effects of endotoxin preparations can be divided into two large groups. One consists of reactions which are harmful and may lead to irreversible vascular collapse, shock and death. The other covers those which are beneficial, such as enhanced immune responsiveness, elevated non-specific resistance to microbial infections including fungi and viruses, increased leukopoiesis, activation of lymphocytes and of the functions of macrophages as well as of the entire reticuloendothelial system. Finally, one should mention the anti-tumor effects of endotoxins on some established animal malignancies and the resistance enhancement to transplantable experimental tumors induced by endotoxin. Table 1 shows some of those endotoxic effects which may be considered as beneficial.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
A. M. Abdelnoor, H. L. Chang, P. H. Pham, and A. Nowotny, Lack of relationship between toxicity and bone marrow cell colony stimulating activity of endotoxin preparations, Proc. Soc. Exp. Biol. Med. 163: 15 (1980).
R. L. Anacker, R. A. Finkelstein, W. T. Haskins, M. Landy, K. C. Milner, E. Ribi, and R. W. Stashak, Origin and properties of naturally occurring hapten from Escherichia coli, J. Bacteriol. 88: 1705 (1964).
U. H. Behling, Alterations of survival and immunity in normal and irradiated mice treated with bacterial endotoxin and its derivatives, Ph.D. Thesis, Temple University, Philadelphia, Pennsylvanyia (1975).
U. H. Behling and A. Nowotny, Immune adjuvancy of lipopolysaccharide and a nontoxic hydrolytic product demonstrating oscillating effects with time, J. Immunology 118: 1905 (1977).
U. H. Behling and A. Nowotny, Long-term adjuvant effect of bacterial endotoxin in prevention and restoration of radiation-caused immunosuppression, Proc. Soc. Exp. Biol. Med. 157: 348 (1978).
U. H. Behling, P. H. Pham, F. Madani, and A. Nowotny, Components of lipopolysaccharide which induce colony stimulation, adjuvancy and radioprotection, in: “Microbiology 1980,” D. Schlessinger, ed., American Society of Microbiology, Washington, D.C. (1980).
U. H. Behling and A. Nowotny, Cyclic changes of positive and negative effects of single endotoxin injection, in: “Bacterial Endotoxins and Host Response,” M. K. Agarwal, ed., Elsevier/North-Holland Biomedical Press (1980).
U. H. Behling and A. Nowotny, Bacterial endotoxins as modulators of specific and non-specific immunity, in: “Regulatory Implication of Oscillatory Dynamics in the Immune Response,” J. Hiernaux and C. DeLisi, eds., CRC Press (1982).
F. M. Berger, The effect of endotoxin on resistance to infections and disease, Adv. Pharmacol 5: 19 (1967).
F. M. Berger, G. M. Fukui, B. J. Ludwig, and J. P. Rosselet, Increase of non-specific resistance to infection by Protodyne, a protein component derived from bacterial protoplasm, Proc. Soc. Exp. Biol. Med. 127: 556 (1968).
A. Boivin, J. Mesrobeanu, and L. Mesrobeanu, Extraction d’un complexe toxique et antigenique a partir du bacille dT Aertrycke, Compt. Rend. Soc. Biol. 114: 307 (1933).
C. E. Bulawa and C.R.H. Raetz, The biosynthesis of gram negative endotoxin: identification and function of UDP-2, 3-Diacylglucosamine in Escherichia coli, J. Biol. Chem. 259: 4846 (1984).
R. C. Butler and A. Nowotny, Combined immunostimulation in the prevention of tumor take in mice using endotoxins, their derivatives and other immune adjuvants, Cancer Immunol. Immunother. 6: 255 (1979).
H. Chang, J. J. Thompson, and A. Nowotny, Release of colony stimulating factor (CSF) by non-endotoxic breakdown products of bacterial lipopoly- saccharides, Immunol. Commun. 3: 401 (1974).
C. M. Change and A. Nowotny, Relation of structure to function in bacterial O-antigens. VII. The biological activity of “lipid A” preparations, Immunochemistry 12: 19 (1975).
J. Choay and M. Sakouhi, Fraction capable of inducing in vivo a resistance to bacterial infections, process for obtaining said fraction from bacteria and drugs containing said fraction, U.S. Patent 4, 148, 877.
M. J. Crutchley, D. G. Marsh, and J. Cameron, Biological studies on free endotoxin and a non-toxic material from culture supernatant fluids of Escherichia coli 078K80 (1968).
K. R. Cundy and A. Nowotny, Quantitative comparison of toxicity parameters of bacterial endotoxins, Proc. Soc. Exptl. Biol. Med. 127: 999 (1968).
S. Frank, S. Specter, A. Nowotny, and H. Friedman, Immunocyte stimulation in vitro by nontoxic bacterial lipopolysaccharide derivatives, J. Immunol. 119: 855 (1977).
G. G. Freeman and J. St. L. Philpot, The preparation and properties of a specific polysaccharide from Bact. typhosum Ty2, Biochem J. 36: 340 (1942). 1
R. C. Goldman and L. Leive, Heterogeneity of antigenic side chain length in LPS from Escherichia coli 0111 and Salmonella typhimurium LT2, Eur. J. Bioch 107: 145 (1980).
N. Haeffner-Cavaillon, J. M. Cavaillon, and L. Szabo, Macrophage dependent polyclonal activation of splenocytes by Bordetella pertussis endotoxin and its isolated polysaccharide and lipid A region, Cell Immunol. 74: 1 (1982).
N. Haeffner-Cavaillon, J. M. Cavaillon, M. Moreau, and L. Szabo, Interleukin secretion by human monocytes stimulated by the isolated polysaccharide region of Bordetella pertussis endotoxin, Mol. Immunol 21: 389 (1984).
N. Haeffner-Cavaillon, J. M. Cavaillon, and L. Szabo, Cellular receptors for endotoxin, in: “Handbook of Endotoxin,” Volume 3, L. J. Berry, ed., Elsevier-North Holland Publishers, Amsterdam and New York (1985).
P. J. Hitchcock and T. M. Brown, Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stain polyacrylamide gels, J. Bacteriol. 154: 269 (1983).
A. G. Johnson and A. Nowotny, Relationship of structure to function in bacterial O-antigens. III. Biological properties of endotoxoids, J. Bact. 87: 809 (1964).
N. Kasai and A. Yamano, Studies of the lipids of endotoxins. Thin layer chromatography of lipid fractions, Jap. Exp. Med. 34: 329 (1964).
S. Lehrer and A. Nowotny, Isolation and purification of endotoxin by hydrolytic enzymes, Inf. and Imm. 6: 928 (1972).
D. G. Marsh and M. J. Crutchley, Purification and physico-chemical analysis of fractions from the culture supernatant of Escherichia coli 078K80: free endotoxin and a non-toxic fraction, Gen. Microbiol 47: 405 (1967).
H. Mayer and J. Weckesser, “Unusual” lipid Afs structures, taxonomical relevance and potential value for endotoxin research, in: “Handbook of Endotoxin,” Vol. 1, E. Rietschel, ed., Elsevier Publishing, Amsterdam and New York (1984).
D. C. Morrison, S. J. Betz, and D. M. Jacobs, Isolation of a lipid A bound polypeptide responsible for “LPS-initiated” mitogenesis of C3H/HeJ spleen cells, J. Exp. Med. 144: 840 (1976).
A. R. Kg, C. M. Chang, G. H. Chen, and A. Nowotny, Comparison of the chemical structure and biological activities of the glycolipids of Salmonella minnesota R595 and Salmonella typhimurium SL1102., Inf. and Immun. 10: 938 (1974).
M. Nishijima and C.R.H. Raetz, Membrane lipid biogenesis in Escherichia coli: identification of genetic loci for phosphotidylglycerol, J. Biol. Chem. 254: 7837 (1979).
A. Nowotny, Chemical structure of a phosphomucolipid and its occurrence in some strains of Salmonella, Am. Chem. Soc. 83: 501 (1961).
A. Nowotny, Endotoxoid preparations, Nature 197: 721 (1963a).
A. Nowotny, Relation of structure to function in bacterial O-antigens. II. Fractionation of lipids present in Boivin-type endotoxin of Serratia marcescens, J. Bact. 85: 427 (1963b).
A. Nowotny, Chemical detoxification of bacterial endotoxins, in: “Bacterial Endotoxins,” M. Landy and W. Braun, eds., Rutgers University Press, New Brunswick, NJ (1964).
A. Nowotny, Relation of chemical structure to pathologic activity of endotoxins, in: “Shock and Hypotension,” L. J. Mills and J. H. Moyer, eds., Grune and Stratton, Inc., New York (1965).
A. Nowotny, Heterogeneity of endotoxic bacterial lipopolysaccharides revealed by ion exchange column chromatography, Nature 210: 278 (1966).
A. Nowotny, Molecular aspects of endotoxic reactions, Bact. Rev. 33: 72 (1969).
A. Nowotny, Chemical and biological heterogeneity of endotoxins, in: “Microbial Toxins,” Vol. IV, Weinbaum et al., eds., Academic Press, New York (1971a).
A. Nowotny, Relationship of structure and biological activity of bacterial endotoxins, Naturwissenschaften 58: 397 (1971b).
A. Nowotny, Relation of structure to function in bacterial endotoxins, in: “Microbiology 1977, ” D. Schlessinger, ed., American Society of Microbiology, Washington, D.C. (1977).
A. Nowotny, “Basic Exercises in Immunochemistry,” 2nd Edition, Springer-Verlag, New York, Heidelberg, Berlin (1979).
A. Nowotny, Heterogeneity of endotoxins, in: “Handbook of Endotoxins,” Vol. 1, E. T. Rietschel, ed., Elsevier, Amsterdam and New York (1984).
A. M. Nowotny, S. Thomas, O. S. Duron, and A. Nowotny, Relations of structure to function in bacterial O-antigens. I. Isolation methods, J. Bact 85: 418 (1963).
A. Nowotny, K. Cundy, N. Neale, A. M. Nowotny, R. Radvany, S. Thomas, and D. Tripodi, Relation of structure to function in bacterterial O-antigens. IV. Fractionation of the components, Ann. N.Y. Acad. Sci. 133: 586 (1966).
A. Nowotny, U. H. Behling, and H. L. Chang, Relation of structure to function in bacterial endotoxins. VIII. Biological activities in a polysaccharide-rich fraction, J. Immunol. 115: 199 (1975).
M. Ohta, M. Mori, T. Hasegawa, F. Hagase, I. Nakashima, S. Naito, and N. Kato, Further studies of the polysaccharide of Klebsiella pneumoniae possessing strong adjuvanticity. I. Production of the adjuvant polysaccharide by non-capsulated mutant, Microbiol. Immunol. 25: 939 (1981).
M. Ohta, J. Rothmann, E. Kovats, P. H. Pham, and A. Nowotny, Biological activities of lipopolysaccharides fractionated by preparative acrylamide gel electrophoresis, Microbiol. Immunol. 29: 1 (1985).
C.R.H. Raetz, S. Purcell, and K. Takayama, Molecular requirements for B-lymphocyte activation by Escherichia coli lipopolysaccharide, Proc. Natl. Acad. Sci. USA 80: 4624 (1983).
D. Raichvarg, C. Brossard, and J. Agneray, Preparation of a nontoxic and immunogenic polysaccharide fraction from a Haemophilus influenza phenol-water extract, Infec. and Immun. 1: 171 (1980a).
D. Raichvarg, M. Guenounou, C. Brossard, J. E. Alouf, and J. Agneray, Endotoxin-like substances in bacterial cell-outer membrane: correlation between structure and biological activities of Haemophilus influenzae type A endotoxin, in: “Bacterial Endotoxins and Host Response,” M. K. Agarwal, ed., Elsevier/North-Holland Biomedical Press (1980b).
B. L. Ray, G. Painter, and C.R.H. Raetz, The biosynthesis of gram negative endotoxin. Formation of lipid A disaccharides from monosaccharide precursors in extracts of Escherichia coli, J. Biol. Chem. 259: 4852 (1984).
E. Ribi, R. Parker, S. M. Strain, Y. Mizuno, A. Nowotny, K. von Eschen, J. L. Cantrell, C. A. McLaughlin, K. M. Hwang, and M. B. Goren, Peptides as requirement for immunotherapy of the guinea-pig line-10 tumor with endotoxin, Cancer Immunol. Immunother. 7: 43 (1979).
E. Ribi, K. Amano, J. Cantrell, S. Shwartzman, R. Parker, and K. Takayama, Preparation and antitumor activity of non-toxic lipid A, Cancer Immunol. Immunother. 12: 91 (1982).
E. Ribi, J. L. Cantrell, K. Takayama, K. Amano, Enhancement of anti-tumor resistance by mycobacterial products and endotoxin, in: “Beneficial Effects of Endotoxins,” A. Nowotny, ed., Plenum Press, New York and London (1983).
E. T. Rietschel, S. Hase, M.-T. King, J. Redmond, and V. Lehmann, Chemical structure of lipid A, in: “Microbiology 1977,” D. Schiessinger, ed., American Society of Microbiology, Washington, D.C. (1977).
N. Rote, The role of long chain carboxylic acid in endotoxin, Ph.D. Thesis, Temple University, Philadelphia, Pennsylvania (1974).
J. Rothman, A. G. Johnson, H. Friedman, E. Kovats, P. H. Pham, F. Sanavi, A. M. Nowotny and A. Nowotny, Biological effects of White-type polysacharides of gram negative bacteria, J. Biol. Res. Mod. 4: 169 (1985).
J. A. Rudbach, R. L. Anacker, W. T. Haskins, K. C. Milner, and E. Ribi, Physical structure of a native protoplasmic polysaccharide from Escherichia coli, J. Immunol. 98: 1 (1967).
J. Samu, E. Kovats, T. Keler, and A. Nowotny, TLC and high-voltage TLC of endotoxins and their derivatives, Abstract, Fifth American-Eastern European Symposium on Liquid Chromatography, Hungarian Chemical Society, Budapest, Hungary (1985).
G. Shwartzman, Studies on Bacillus typhosus toxic substance. I. The phenomenon of local reactivity to B. Typhosus culture filtrate, J. Exp. Med. 48: 247 (1928).
B. M. Sultzer, Chemical modification of endotoxin and inactivation of its biological properties, in: “Microbial Toxins,” Vol. 5, Kadis et al., eds., Academic Press, New York (1971).
B. M. Sultzer and G. W. Goodman, Endotoxin protein: A B-cell mitogen and polyclonal activator of C3H/HeJ lymphocytes, J. Exp. Med. 144: 821 (1976).
K. Takayama, E. Ribi, and J. L. Cantrell, Isolation of a nontoxic Lipid A fraction containing tumor regression activity, Cancer Res. 41: 821 (1981).
D. Tripodi, Active sites of Serratia marcescens endotoxin preparations, Ph.D. Thesis, Temple University, Philadelphia, Pennsylvanyia (1965).
D. Tripodi and A. Nowotny, Relation of structure to function in bacterial O-antigens. V. Nature of active sites in endotoxic lipopolysaccharides of Serratia marcescens, Ann. N.Y. Acad. Sci. 133: 604 (1966).
C. M. Tsai and C. E. Frash, A sensitive silver stain for detecting lipopolysaccharide in Polyacrylamide gels, Anal. Biochem. 119: 115 (1982).
R. Urbaschek, Effects of bacterial products in granulopoiesis, Adv. Exp. Med. Biol. 121B-. 51 (1980).
O. Westphal and O. Luderitz, Chemische Erforschung von Lipopolysac- chariden gram negativer Bakterien, Angew. Chem. 66: 407 (1954).
O. Westphal, A. Nowotny, O. Luderitz, H. Hurni, E. Eichenberger, and G. Schonholzer, The significance of the lipid component (lipid A) in the biological activities of bacterial endotoxins (lipopolysaccharides), Pharmeceutica. Acta. Helvetica (Germany) 33: 401 (1958).
O. Westphal, O. Luderitz, E. T. Rietschel, and C. Galanos, Bacterial lipopolysaccharide and its lipid A component: some historical and some current aspects, Biochem. Soc. Trans. 9: 191 (1980).
P. B. White, Notes on intestinal bacilli with special reference to smooth and rough races, J. Path, and. Bact 32: 85 (1929).
P. D. Wightman and C.R.H. Wightman, The activation of protein kinase C by biologically active lipid moieties of lipopolysaccharide, J. Biol. Chem 259: 10048 (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Nowotny, A. (1986). Beneficially Active Structural Entities in Endotoxin Preparations. In: Szentivanyi, A., Friedman, H., Nowotny, A. (eds) Immunobiology and Immunopharmacology of Bacterial Endotoxins. University of South Florida International Biomedical Symposia Series, vol 18. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2253-5_3
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2253-5_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9319-4
Online ISBN: 978-1-4613-2253-5
eBook Packages: Springer Book Archive